prikaz prve stranice dokumenta Plasma levels of soluble TGF β receptor type III: no apparent promise as a marker in acute pancreatitis
  Preuzmi
PDF 310.97 KB
Znanstveni rad - Izvorni znanstveni rad
Plasma levels of soluble TGF β receptor type III: no apparent promise as a marker in acute pancreatitis
Croatian Medical Journal, 62 (2021), 3; 264-269. https://doi.org/10.3325/cmj.2021.62.264
Salai, Grgur; Zelenika, Marko; Hrkač, Stela; Trkulja, Vladimir; Bilandžić, Joško; Grgurević, Ivica; Novak, Ruđer; Grgurević, Lovorka

Citirajte ovaj rad

Salai, G., Zelenika, M., Hrkač, S., Trkulja, V., Bilandžić, J., Grgurević, I. ... Grgurević, L. (2021). Plasma levels of soluble TGF β receptor type III: no apparent promise as a marker in acute pancreatitis. Croatian Medical Journal, 62. (3), 264-269. doi: 10.3325/cmj.2021.62.264

Salai, Grgur, et al. "Plasma levels of soluble TGF β receptor type III: no apparent promise as a marker in acute pancreatitis." Croatian Medical Journal, vol. 62, br. 3, 2021, str. 264-269. https://doi.org/10.3325/cmj.2021.62.264

Salai, Grgur, Marko Zelenika, Stela Hrkač, Vladimir Trkulja, Joško Bilandžić, Ivica Grgurević, Ruđer Novak i Lovorka Grgurević. "Plasma levels of soluble TGF β receptor type III: no apparent promise as a marker in acute pancreatitis." Croatian Medical Journal 62, br. 3 (2021): 264-269. https://doi.org/10.3325/cmj.2021.62.264

Salai, G., et al. (2021) 'Plasma levels of soluble TGF β receptor type III: no apparent promise as a marker in acute pancreatitis', Croatian Medical Journal, 62(3), str. 264-269. doi: 10.3325/cmj.2021.62.264

Salai G, Zelenika M, Hrkač S, Trkulja V, Bilandžić J, Grgurević I, i sur.. Plasma levels of soluble TGF β receptor type III: no apparent promise as a marker in acute pancreatitis. Croatian Medical Journal [Internet]. 30.06.2021. [pristupljeno 19.12.2024.];62(3):264-269. doi: 10.3325/cmj.2021.62.264

G. Salai, et al., "Plasma levels of soluble TGF β receptor type III: no apparent promise as a marker in acute pancreatitis", Croatian Medical Journal, vol. 62, br. 3, str. 264-269, Lipanj 2021. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:377435. [Citirano: 19.12.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:377435
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Plasma levels of soluble TGF β receptor type III: no apparent promise as a marker in acute pancreatitis
AutorGrgur Salai
AutorMarko Zelenika
AutorStela Hrkač
AutorVladimir Trkulja
AutorJoško Bilandžić
AutorIvica Grgurević
AutorRuđer Novak
AutorLovorka Grgurević
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA ANATOMIJU)
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA TEMELJNU I KLINIČKU FARMAKOLOGIJU)
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA INTERNU MEDICINU)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Temeljne medicinske znanosti
Anatomija
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Temeljne medicinske znanosti
Farmakologija
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (engleski)
Aim: To assess the potential of the soluble transforming growth factor β receptor type III (sTGFβrIII), a key regulator in TGFβ signaling, as a biomarker for diagnosis and stratification of patients with acute pancreatitis (AP). ------ Methods: In this small prospective pilot study, patients' (N=22) plasma samples were obtained at three time points: the first and fourth day of hospitalization and the day of hospital discharge. Healthy controls' plasma (N=25) was obtained at a single time point. Concentration of sTGFβrIII in plasma was determined by ELISA. Data were analyzed by fitting linear or linear mixed models. ----- Results: Plasma sTGFβrIII levels at presentation (day 1) were similar in AP patients and healthy participants, irrespectively of the disease severity. sTGFβrIII levels in patients were constant during hospital stay. ----- Conclusion: These observations do not support further evaluation of plasma sTGFβrIII levels in this setting, but do not exclude a potential biological role of TGFβ and membrane-bound TGFβrIII in AP pathophysiology.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaCroatian Medical Journal
Brojčani podacivol. 62, br. 3, str. 264-269
p-ISSN0353-9504
e-ISSN1332-8166
DOIhttps://doi.org/10.3325/cmj.2021.62.264
URN:NBNurn:nbn:hr:105:377435
Datum objave publikacije2021-06-30
URL dokumentahttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275940/
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje-Nekomercijalno-Bez prerada 4.0 međunarodna (CC BY-NC-ND 4.0)
Datum i vrijeme pohrane2021-07-28 08:40:03